First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
The RH5.1/Matrix-M blood-stage vaccine could constitute a crucial secondary defence for communities at high risk of malaria infection, including those…
News
Alumis reports positive outcomes from Phase I trial of TYK2 inhibitor
Novo Nordisk takes a hit as CagriSema underperforms in weight loss
Adicet Bio doses first subject in Phase I trial of renal cell carcinoma therapy
Sorriso Pharma’s UC treatment hits Phase Ib endpoints
MSD’s DOR/ISL regimen meets primary efficacy hypotheses in HIV-1 treatment trials
APAC leading in Parkinson’s disease clinical trials
Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo
